140 related articles for article (PubMed ID: 38604649)
1. Maternal and infant outcomes in women with sickle cell disease: a matched cohort study.
Sikdar O; Ambulkar H; Jenkinson A; Hedley C; Johns J; Bhat R; Dassios T; Harris C; Greenough A
Arch Dis Child Fetal Neonatal Ed; 2024 Apr; ():. PubMed ID: 38604649
[TBL] [Abstract][Full Text] [Related]
2. Maternal morbidity and mortality associated with mode of delivery in sickle cell disease.
Martinborough T; Allen-Davis W; Hunter-Greaves T; Thame M; Reid M; Simms-Stewart D
J Obstet Gynaecol; 2022 Nov; 42(8):3560-3567. PubMed ID: 36541410
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Rankine-Mullings AE; Nevitt SJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt SJ; Jones AP; Howard J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
[TBL] [Abstract][Full Text] [Related]
5. Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK.
Oakley LL; Mitchell S; von Rege I; Hadebe R; Howard J; Robinson SE; Oteng-Ntim E
Br J Haematol; 2022 Feb; 196(4):1069-1075. PubMed ID: 34881428
[TBL] [Abstract][Full Text] [Related]
6. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome in patients with sickle cell disease in the UK--a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease.
Oteng-Ntim E; Ayensah B; Knight M; Howard J
Br J Haematol; 2015 Apr; 169(1):129-37. PubMed ID: 25522142
[TBL] [Abstract][Full Text] [Related]
8. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
Ogedengbe OK; Akinyanju O
West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
[TBL] [Abstract][Full Text] [Related]
9. Preoperative blood transfusions for sickle cell disease.
Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy.
Okusanya BO; Oladapo OT
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010378. PubMed ID: 28005272
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
Addai FK; Wilson JB; Quashie FJ
Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
[TBL] [Abstract][Full Text] [Related]
12. Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease.
Antwi-Boasiako C; Kusi-Mensah YA; Hayfron-Benjamin C; Aryee R; Dankwah GB; Kwawukume LA; Darkwa EO
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470666
[No Abstract] [Full Text] [Related]
13. Adverse clinical and obstetric outcomes among pregnant women with different sickle cell disease genotypes.
Silva FAC; Ferreira ALCG; Hazin-Costa MF; Dias MLG; Araújo AS; Souza AI
Int J Gynaecol Obstet; 2018 Oct; 143(1):89-93. PubMed ID: 30030929
[TBL] [Abstract][Full Text] [Related]
14. Profile of Reproductive Issues Associated with Different Sickle Cell Disease Genotypes.
Carvalho FA; Souza AI; Ferreira ALCG; Neto SDS; Oliveira ACPL; Gomes MLRP; Costa MFH
Rev Bras Ginecol Obstet; 2017 Aug; 39(8):397-402. PubMed ID: 28683515
[No Abstract] [Full Text] [Related]
15. The influence of infant and maternal sickle cell disease on birth outcome and neonatal course.
Brown AK; Sleeper LA; Pegelow CH; Miller ST; Gill FM; Waclawiw MA
Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1156-62. PubMed ID: 7921116
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting.
Oppong SA; Asare EV; Olayemi E; Boafor T; Dei-Adomakoh Y; Swarry-Deen A; Mensah E; Osei-Bonsu Y; Crabbe S; Musah L; Hayfron-Benjamin C; Covert B; Kassim AA; James A; Rodeghier M; Audet C; DeBaun MR
Am J Hematol; 2019 Feb; 94(2):223-230. PubMed ID: 30456766
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes.
Costa VM; Viana MB; Aguiar RA
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):685-9. PubMed ID: 24866352
[TBL] [Abstract][Full Text] [Related]
18. Current obstetric outcomes in Jamaican women with sickle hemoglobinopathy - a balance of risks for aspirin?
Gibson SMP; Hunter TA; Charles PE; Morgan MAC; Griffith-Anderson SKR; Cruickshank JK; Gossell-Williams MD; Johnson NA
J Perinat Med; 2024 Jun; 52(5):485-493. PubMed ID: 38629833
[TBL] [Abstract][Full Text] [Related]
19. Most adults with severe HbSC disease are not treated with hydroxyurea.
Ghunney WK; Asare EV; Ayete-Nyampong JB; Oppong SA; Rodeghier M; DeBaun MR; Olayemi E
Blood Adv; 2023 Jul; 7(13):3312-3319. PubMed ID: 36799926
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic analysis in placentas from sickle cell disease patients reveals a hypermethylation profile.
Gil GP; Ananina G; Maschietto M; Lima SCS; da Silva Costa SM; Baptista LC; Ito MT; Costa FF; Costa ML; de Melo MB
PLoS One; 2022; 17(9):e0274762. PubMed ID: 36129958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
